Your search for fibromyalgia returned 175 results

Cognitive-behavioral therapy exerts benefits by altering the connectivity of specific regions of the brain.

Cognitive-behavioral therapy exerts benefits by altering the connectivity of specific regions of the brain.

New instrument, the Pain-related OUD Exacerbation Scale, shows validity

Small study suggests green light therapy might reduce anxiety in patients with fibromyalgia who are taking opioids for chronic pain

The FDA cleared the device based on data from a placebo-controlled, randomized, double-blind, parallel group clinical study.

The Quell® neuromodulation device (NeuroMetrix) has received the Food and Drug Administration De Novo authorization for use as an aid in reducing the symptoms of fibromyalgia in adults with high pain sensitivity. Quell is a transcutaneous electrical nerve stimulator (TENS) that is worn on the upper calf. The device delivers electrical stimulation to the user…

The phase 3 RALLY study is evaluating the efficacy and safety of TNX-102 SL in 514 adult patients with fibromyalgia.

To assess the effectiveness of these therapies on pain reduction and quality of life improvement, study authors searched various databases for randomized or quasi-randomized clinical trials that evaluated these outcomes in fibromyalgia patients.

The Food and Drug Administration (FDA) has expanded the approval of Cymbalta (duloxetine; Lilly) to include treatment of fibromyalgia in pediatric patients 13 to 17 years of age.

Greater decline seen in movement-evoked pain, fatigue; more improvement found on global impression of change